Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancers"
DOI: 10.3390/cancers12041034
Abstract: Clinical results with oncolytic adenoviruses (OAds) used as antitumor monotherapies show limited efficacy. To increase OAd potency, transgenes have been inserted into their genome, a strategy known as “arming OAds”. Here, we review different parameters…
read more here.
Keywords:
transcriptional control;
control elements;
oncolytic adenoviruses;
transgene location ... See more keywords